"Cherry Blossom" in Kyoto Brought Hope to Patients with Chronic Hepatitis B Infection
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Chen G, Wang C, Lau G
. Treatment of chronic hepatitis B infection-2017. Liver Int. 2017; 37 Suppl 1:59-66.
DOI: 10.1111/liv.13309.
View
2.
. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022; 7(9):796-829.
PMC: 9349325.
DOI: 10.1016/S2468-1253(22)00124-8.
View
2.
Zhang S, Wang C, Liu B, Lu Q, Shang J, Zhou Y
. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation. Lancet Reg Health West Pac. 2023; 35:100738.
PMC: 10326688.
DOI: 10.1016/j.lanwpc.2023.100738.
View
3.
You H, Wang F, Li T, Xu X, Sun Y, Nan Y
. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022). J Clin Transl Hepatol. 2023; 11(6):1425-1442.
PMC: 10500285.
DOI: 10.14218/JCTH.2023.00320.
View
4.
Chen J, Lau G
. HBV "Viral Elimination" in the Asia-Pacific region: Current status and challenges. Clin Liver Dis (Hoboken). 2024; 23(1):e0132.
PMC: 10919499.
DOI: 10.1097/CLD.0000000000000132.
View